Literature DB >> 8685053

Analysis of the oxidative catabolism of retinoic acid in rat Dunning R3327G prostate tumors.

M D Krekels1, J Zimmerman, B Janssens, R Van Ginckel, W Cools, C Van Hove, M C Coene, W Wouters.   

Abstract

We studied the enzymatic characteristics of the oxidative catabolism of retinoic acid (RA) and its inhibition by liarozole-fumarate in homogenates of rat Dunning R3327G prostate tumors. Homogenates of rat liver were used as reference material. Both tumor and liver homogenates were able to catabolize retinoic acid. HPLC analysis revealed only very polar metabolites in tumors, while in the liver both metabolites with intermediate polarity and more polar metabolites were found. Kinetic analysis of retinoic acid catabolism showed a K(m) of 1.7 +/- 0.7 microM and a Vmax of 4.2 +/- 4.4 pmol polar RA metabolites/mg protein/hr for Dunning G tumor homogenates. In liver homogenates a K(m) value of 4.3 +/- 0.5 microM and a Vmax value of 290 +/- 120 pmol polar RA metabolites/mg protein/hr were obtained. Liarozole-fumarate inhibited retinoic acid catabolism in Dunning tumors and liver with IC50 values of 0.26 +/- 0.16 microM and 0.14 +/- 0.05, respectively. The results suggest that rat Dunning R3327G tumors are able to metabolize retinoic acid in a manner similar to that found in rat liver but with a lower metabolizing capacity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8685053     DOI: 10.1002/(SICI)1097-0045(199607)29:1<36::AID-PROS5>3.0.CO;2-G

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  6 in total

1.  First chemical feature-based pharmacophore modeling of potent retinoidal retinoic acid metabolism blocking agents (RAMBAs): identification of novel RAMBA scaffolds.

Authors:  Puranik Purushottamachar; Jyoti B Patel; Lalji K Gediya; Omoshile O Clement; Vincent C O Njar
Journal:  Eur J Med Chem       Date:  2011-11-17       Impact factor: 6.514

2.  Liarozole.

Authors:  H M Bryson; A J Wagstaff
Journal:  Drugs Aging       Date:  1996-12       Impact factor: 3.923

Review 3.  Therapeutic potential of the inhibition of the retinoic acid hydroxylases CYP26A1 and CYP26B1 by xenobiotics.

Authors:  Cara H Nelson; Brian R Buttrick; Nina Isoherranen
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

4.  The antiproliferative activity of all-trans-retinoic acid catabolites and isomers is differentially modulated by liarozole-fumarate in MCF-7 human breast cancer cells.

Authors:  J Van heusden; W Wouters; F C Ramaekers; M D Krekels; L Dillen; M Borgers; G Smets
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

5.  All-trans-retinoic acid metabolites significantly inhibit the proliferation of MCF-7 human breast cancer cells in vitro.

Authors:  J Van heusden; W Wouters; F C Ramaekers; M D Krekels; L Dillen; M Borgers; G Smets
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

Review 6.  Are gene expression microarray analyses reliable? A review of studies of retinoic acid responsive genes.

Authors:  Peter J van der Spek; Andreas Kremer; Lynn Murry; Michael G Walker
Journal:  Genomics Proteomics Bioinformatics       Date:  2003-02       Impact factor: 7.691

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.